» Articles » PMID: 10699186

Beta-globin YAC Transgenes Exhibit Uniform Expression Levels but Position Effect Variegation in Mice

Overview
Journal Hum Mol Genet
Date 2000 Mar 4
PMID 10699186
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Expression of a construct integrated at different genomic locations often varies because of position effects that have been subcategorized as stable (decreased level of expression) and variegating (decreased proportion of expressing cells). It is well established that locus control regions (LCRs) generally overcome position effects in transgenes. However, whether stable and variegated position effects are equally overcome by an intact LCR has not been determined. We report that single-copy yeast artificial chromosome transgenes containing an unmodified human beta -globin locus were not subject to detectable stable position effects but did undergo mild to severe variegating position effects at three of the four non-centromeric integration sites tested. We also find that, at a given integration site, the distance and the orientation of the LCR relative to the regulated gene contributes to the likelihood of variegating position effects, and can affect the magnitude of its transcriptional enhancement. DNase I hypersensitive site (HSS) formation varies with the proportion of expressing cells, not the level of gene expression, suggesting that silencing of the transgene is associated with a lack of HSS formation in the LCR region. We conclude that transcriptional enhancement and variegating position effects are caused by fundamentally different but inter-dependent mechanisms.

Citing Articles

Comparison of two related lines of tauGFP transgenic mice designed for lineage tracing.

Sharp L, Pratt T, MacKay G, Keighren M, Flockhart J, Chandler E BMC Dev Biol. 2017; 17(1):8.

PMID: 28662681 PMC: 5492368. DOI: 10.1186/s12861-017-0149-x.


Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium.

Shafique E, Torina A, Reichert K, Colantuono B, Nur N, Ravichandran V Cardiovasc Res. 2017; 113(2):234-246.

PMID: 28088753 PMC: 5340144. DOI: 10.1093/cvr/cvw249.


Current and future alternative therapies for beta-thalassemia major.

de Dreuzy E, Bhukhai K, Leboulch P, Payen E Biomed J. 2016; 39(1):24-38.

PMID: 27105596 PMC: 6138429. DOI: 10.1016/j.bj.2015.10.001.


In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain.

Suzuki N, Mukai H, Yamamoto M PLoS One. 2015; 10(3):e0119442.

PMID: 25790231 PMC: 4366189. DOI: 10.1371/journal.pone.0119442.


Mice expressing RHAG and RHD human blood group genes.

Goossens D, da Silva N, Metral S, Cortes U, Callebaut I, Picot J PLoS One. 2013; 8(11):e80460.

PMID: 24260394 PMC: 3832391. DOI: 10.1371/journal.pone.0080460.